General MedicationsINTRAVENOUSStandard

FOCINVEZ

FOSAPREPITANT DIMEGLUMINE

Standard Dose

EQ 150MG BASE/50ML (EQ 3MG BASE/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview FOCINVEZ is listed in Drugs@FDA under application 216686 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FOSAPREPITANT DIMEGLUMINE Form and strength SOLUTION;INTRAVENOUS - EQ 150MG BASE/50ML (EQ 3MG BASE/ML) Sponsor STERISCIENCE Submission history Latest submission status date: 2026-03-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview FOCINVEZ is listed in Drugs@FDA under application 216686 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FOSAPREPITANT DIMEGLUMINE Form and strength SOLUTION;INTRAVENOUS - EQ 150MG BASE/50ML (EQ 3MG BASE/ML) Sponsor STERISCIENCE Submission history Latest submission status date: 2026-03-30 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.